IL-32 up-regulation is associated with inflammatory cytokine production in allergic rhinitis

Journal of Pathology

Volumn 224, Issue 4, 2011, Pages 553-563

  Jeong, Hyun Ja ^a   Shin, Seung Youp ^b   Oh, Hyun A ^c   Kim, Min Ho ^d   Cho, Joong Saeng ^b   Kim, Hyung Min ^c  

^a Hoseo University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Kyung Hee University   (South Korea)

^d Chonbuk National University   (South Korea)

Author keywords

allergic rhinitis; caspase 1; granulocyte macrophage colony stimulating factor; inflammatory cytokines; interleukin 32

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 32; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ALLERGIC RHINITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MAJOR CLINICAL STUDY; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ADENOIDS; ADOLESCENT; ADULT; ANIMALS; CASPASE 1; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; HYPEREOSINOPHILIC SYNDROME; IMMUNOGLOBULIN E; INFLAMMATION MEDIATORS; INTERLEUKINS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; NASAL MUCOSA; RESPIRATORY HYPERSENSITIVITY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHINITIS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 79960007377     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2899     Document Type: Article

References (35)

1. Bousquet J, Khaltaev N, Cruz AA, et al., World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008; 63 (Suppl 86): 8-160. (Pubitemid 351357811)
2. Bousquet J, Jacot W, Vignola AM, et al., Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004; 113: 43-49. (Pubitemid 38096160)
3. Howarth PH,. Allergic and nonallergic rhinitis. In Allergy, Principles and Practice (6th edn), Middleton E, Reed C, Ellis E, et al (eds). Allergic and Nonallergic Rhinitis, Vol 2. Mosby: Philadelphia, 2003; 1391-1410.
4. Johansson SJ, Hourithane JO, Bouquet J, et al., A revised nomenclature for allergy: an EAACI position statement from the EAACI nomenclature task force. Allergy 1991; 56: 813-824.
5. Durham SR, Ying S, Varney VA, et al., Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol 1992; 148: 2390-2394.
6. Bournazou I, Mackenzie KJ, Duffin R, et al., Inhibition of eosinophil migration by lactoferrin. Immunol Cell Biol 2010; 88: 220-223.
7. Tai PC, Spry CJ,. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils. Clin Exp Immunol 1990; 80: 426-434. (Pubitemid 20180340)
8. Kim SH, Han SY, Azam T, et al., Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005; 22: 131-142.
9. Netea MG, Azam T, Ferwerda G, et al., IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A 2005; 102: 16309-16314. (Pubitemid 41688910)
10. Meyer N, Zimmermann M, Bürgler S, et al., IL-32 is expressed by human primary keratinocytes and modulates keratinocyte apoptosis in atopic dermatitis. J Allergy Clin Immunol 2010; 125: 858-865.
11. Kempuraj D, Conti P, Vasiadi M, et al., IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol 2010; 20: 865-867.
12. Joosten LA, Netea MG, Kim SH, et al., IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci U S A 2006; 103: 3298-3303. (Pubitemid 43346464)
13. Goda C, Kanaji T, Kanaji S, et al., Involvement of IL-32 in activation-induced cell death in T cells. Int Immunol 2006; 18: 233-240. (Pubitemid 43160136)
14. Choi JD, Bae SY, Hong JW, et al., Identification of the most active interleukin-32 isoform. Immunology 2009; 126: 535-542.
15. Netea MG, Azam T, Lewis EC, et al., Mycobacterium tuberculosis induces interleukin-32 production through a caspase-18/interferon-gamma-dependent mechanism. PLoS Med 2006; 3: e277.
16. Lee S, Kim JH, Kim H, et al., Activation of the interleukin-32 pro-inflammatory pathway in response to human papillomavirus infection and over-expression of interleukin-32 controls the expression of the human papillomavirus oncogene. Immunology 2011; 132: 410-420.
17. Shioya M, Nishida A, Yagi Y, et al., Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007; 149: 480-486. (Pubitemid 47256156)
18. Calabrese F, Baraldo S, Bazzan E, et al., IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 894-901.
19. Kobayashi H, Huang J, Ye F, et al., Interleukin-32beta propagates vascular inflammation and exacerbates sepsis in a mouse model. PLoS One 2010; 5: e9458.
20. Netea MG, Lewis EC, Azam T, et al., Interleukin-32 induces the differentiation of monocytes into macrophage-like cells. Proc Natl Acad Sci U S A 2008; 105: 3515-3520. (Pubitemid 351723584)
21. Mabilleau G, Sabokbar A,. Interleukin-32 promotes osteoclast differentiation but not osteoclast activation. PLoS One 2009; 4: e4173.
22. Dahl CA, Schall RP, He HL, et al., Identification of a novel gene expressed in activated natural killer cells and T cells. J Immunol 1992; 148: 597-603.
23. Alsaleh G, Sparsa L, Chatelus E, et al., Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010; 12: R135.
24. Nishida A, Andoh A, Shioya M, et al., Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-32α induction in human pancreatic periacinar myofibroblasts. Am J Physiol Gastrointest Liver Physiol 2008; 294: G831-G838. (Pubitemid 351468765)
25. Ko NY, Mun SH, Lee SH, et al., Interleukin-32α production is regulated by MyD88-dependent and independent pathways in IL-1β-stimulated human alveolar epithelial cells. Immunobiology 2011; 216: 32-40.
26. Fuentes-Beltrán A, Montes-Vizuet R, Valencia-Maqueda E, et al., Chemokine CC-ligand 5 production and eosinophil activation into the upper airways of aspirin-sensitive patients. Clin Exp Allergy 2009; 39: 491-499.
27. Woschnagg C, Rubin J, Venge P,. Eosinophil cationic protein (ECP) is processed during secretion. J Immunol 2009; 183: 3949-3954.
28. Rothenberg ME, Hogan SP,. The eosinophil. Annu Rev Immunol 2006; 24: 147-174.
29. Gleich GJ,. Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-663. (Pubitemid 30226437)
30. Hamilton JA,. GM-CSF in inflammation and autoimmunity. Trends Immunol 2002; 23: 403-408. (Pubitemid 34804636)
31. Fleetwood AJ, Cook AD, Hamilton JA,. Functions of granulocyte-macrophage colony-stimulating factor. Crit Rev Immunol 2005; 25: 405-428. (Pubitemid 43068934)
32. Martinon F,. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 2005; 26: 447-454. (Pubitemid 41008082)
33. Kobayashi K, Inohara N, Hernandez LD, et al., RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 2002; 416: 194-199. (Pubitemid 34246479)
34. Martinon F, Tschopp J,. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574. (Pubitemid 38692523)
35. Yoo NJ, Park WS, Kim SY, et al., Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem Biophys Res Commun 2002; 299: 652-658. (Pubitemid 36034595)